Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 6/20 | 0.69 |
| ▸ | ESR1 | P03372 | 2/20 | 0.57 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | XDH | P47989 | 1/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4137305 | 0.88 | SERPINE1 (0.73) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL27960493 | 0.87 | SERPINE1 (0.67) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL6580266 | 0.86 | ALDH1A1 (0.59) | SERPINE1PTPN2PTPN1PTPN11L3MBTL1 | |
| SCHEMBL24871463 | 0.85 | SERPINE1 (0.73) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL16684072 | 0.84 | SERPINE1 (0.63) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL20068189 | 0.84 | ESR1 (0.58) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL16155099 | 0.83 | SERPINE1 (0.71) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL20644673 | 0.83 | CA12 (0.58) | SERPINE1ESR1PTPN2PTPN1PTPN11 | |
| SCHEMBL39762 | 0.83 | CA12 (0.63) | SERPINE1ESR1KDM4EGAATDP1 | |
| SCHEMBL39597 | 0.82 | PTPN1 (0.71) | SERPINE1ESR1PTPN1L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250275997-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BONAFIDE HEALTH, LLC | 2025-09-04 | — | — | US | claimed |
| US-12303524-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | MSI-195 HOLDINGS, LLC (US) | 2025-05-20 | — | — | US | claimed |
| CN-115353853-B | Double-component polyurethane adhesive and preparation method and application thereof | 杭州之江有机硅化工有限公司 | 2023-08-01 | — | — | CN | claimed |
| CN-115353853-A | Two-component polyurethane adhesive and preparation method and application thereof | 杭州之江有机硅化工有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-114748459-A | Application of gallic acid in preparing medicine for preventing and treating colibacillosis | 中国农业大学 | 2022-07-15 | — | — | CN | claimed |
| US-20220031729-A1 | USE OF S-ADENOSYLMETHIONINE FOR PERSONALIZED TREATMENT OF DEPRESSION | Zentar LLC (US) | 2022-02-03 | — | — | US | claimed |
| CN-108272862-B | Pudilan oral spray and preparation method thereof | 济川药业集团有限公司 | 2021-01-05 | — | — | CN | claimed |
| CN-108272862-A | A kind of Pudilan oral spray and preparation method thereof | 济川药业集团有限公司 | 2018-07-13 | — | — | CN | claimed |
| US-9925208-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2018-03-27 | — | — | US | claimed |
| US-9801896-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2017-10-31 | — | — | US | claimed |
| EP-1512323-B1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | AIR LIQUIDE SANTE INT (FR) | 2007-02-21 | — | — | EP | claimed |
| EP-1604660-A1 | MEDICINAL COMPOSITION FOR TREATING INFECTION WITH DRUG-RESISTANT STAPHYLOCOCCUS AUREUS | Alps Pharmaceutical Ind. Co. Ltd. (JP) | 2005-12-14 | — | — | EP | claimed |
| US-20050054642-A1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | SCHULKE & MAYR GMBH (DE) | 2005-03-10 | — | — | US | claimed |
| EP-1512323-A1 | Microbicidal composition based on formaldehyde donor compounds and antioxidants | Air Liquide Santé (International) (FR) | 2005-03-09 | — | — | EP | claimed |
| EP-0420893-B1 | REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF | BOEHRINGER MANNHEIM CORP (US) | 1995-07-26 | — | — | EP | claimed |
| US-5084395-A | A chromogen and a pyrogallol derivative as a detector | BOEHRINGER MANNHEIM GMBH (DE) | 1992-01-28 | — | — | US | claimed |
| EP-0420893-A4 | REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF | — | 1991-09-25 | — | — | EP | claimed |
| EP-0420893-A1 | REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF. | BOEHRINGER MANNHEIM CORP (US) | 1991-04-10 | — | — | EP | claimed |
| US-4971918-A | KIT WITH A DETECTABLE COLOR SIGNAL FOR DETECTION OF BLOOD, UR INE ETC FOR DRUGS, GLUCOSE | BOEHRINGER MANNHEIM CORPORATION (US) | 1990-11-20 | — | — | US | claimed |
| WO-1989011643-A1 | REDUCIBLE INDICATORS CONTAINING PYROGALLOL AND USE THEREOF | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-11-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250275997-A1 | Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester | BHMT2, BHMT, MAT1A | SERPINE1 2043/4885ESR1 598/4885PTPN2 4835/4885 |
| US-20220031729-A1 | USE OF S-ADENOSYLMETHIONINE FOR PERSONALIZED TREATMENT OF DEPRESSION | BHMT2, BHMT, MAT2A | SERPINE1 3581/4885ESR1 1471/4885PTPN2 4343/4885 |
| US-12303524-B2 | Compositions comprising S-adenosylmethionine and a gallic acid ester | BHMT2, BHMT, MAT1A | SERPINE1 2043/4885ESR1 598/4885PTPN2 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.